| Enhancer ID: | E_02_0534 |
| Species: | human |
| Position : | chr19:33297216-33299216 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Acute myeloid leukemia |
| Pubmed ID: | 30002127 |
| Enhancer experiment: | Western blot, real time PCR, statistical analysis |
| Enhancer experiment description: | Lack of, aberrant or suboptimal C/EBP? activity can result from genomic mutations in the CEBPA gene,8 transcriptional suppression originating from promoter hypermethylation, or functional inactivation by phosphorylation. |
| Target gene : | CEBPA(C/ebpalpha,CBF-A,Cebp) |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Lack of, aberrant or suboptimal C/EBP? activity can result from genomic mutations in the CEBPA gene,8 transcriptional suppression originating from promoter hypermethylation, or functional inactivation by phosphorylation. |
| TF name : | -- |
| TF experiment: | Western blot,Real-Time PCR,???? |
| TF experiment description: | Lack of, aberrant or suboptimal C/EBP? activity can result from genomic mutations in the CEBPA gene,8 transcriptional suppression originating from promoter hypermethylation, or functional inactivation by phosphorylation. |
| Enhancer function : | Lack of, aberrant or suboptimal C/EBP? activity can result from genomic mutations in the CEBPA gene,8 transcriptional suppression originating from promoter hypermethylation, or functional inactivation by phosphorylation. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Lack of, aberrant or suboptimal C/EBP? activity can result from genomic mutations in the CEBPA gene,8 transcriptional suppression originating from promoter hypermethylation, or functional inactivation by phosphorylation. |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|